Stocks
Scotiabank Sticks to Buy Rating on AbbVie Amid Cautionary Citi Call
Louise Chen from Scotiabank has maintained her Buy rating on AbbVie (ABBV) in a recent report. The price target remains at $280.00, which is based on Chen's expertise in the Healthcare sector.
Chen covers several key stocks, including Johnson & Johnson, Merck & Company, and Teva Pharmaceutical. According to TipRanks, Chen has an average return of 7.0% and a success rate of 53.05% on her recommended stocks.
Absent from the report is any mention of dissenting views or cautionary notes. However, it's worth noting that Citi has also weighed in on AbbVie (ABBV), maintaining a Hold rating today.